Resources

Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C

Showing 71 to 80 of 124 resources

  • National Clinical Guidelines for the treatment of HCV in adults
    These guidelines provide expert guidance to Health Boards, Area Drug and Therapeutics Committees, and treating clinicians on the efficacy of available treatments for hepatitis C. They also act as a clinical reference source for NHS National Procurement to produce rankings on cost-effectiveness.

    Development of the guidance was a collaboration between Scotland's viral hepatitis clinical leads and MCN co-ordinators network, National Services Scotland, and Healthcare Improvement Scotland.
    Scotland Sep 2015 Other, Strategy & Planning PDF
  • Opt-out blood-borne virus test algorithm guidance notes
    This document, published by Public Health England, provides guidance to prisons on how the opt-out blood-borne virus testing programme should be implemented; detailing the responsibilities of prison healthcare teams throughout the testing, treatment and release process.
    UK, England Sep 2015 Other, Training, Strategy & Planning PDF
  • Opt-out BBV testing algorithm
    This chart, which was produced by Public Health England and which is accompanied by guidance notes, provides information for prison healthcare staff on the process by which the opt-out BBV testing policy should be implemented.
    UK, England Sep 2015 Other, Training, Strategy & Planning PDF
  • Scottish Sexual Health and Blood Borne Virus Framework 2015 - 2020
    The Sexual Health and Blood Borne Virus Framework, published by the Scottish Government, drives hepatitis C strategy in Scotland. The 2011 - 2015 version of the Framework led to significant improvements in the way in which the virus was managed in Scotland, and the new incarnation of the Framework seeks to sustain and build upon this progress.
    UK, Scotland Sep 2015 Other, Strategy & Planning PDF
  • Summary report: National event for early lessons learnt from the opt-out blood-borne virus (BBV) testing policy in prisons
    The ‘National event for early lessons learnt from the opt-out Blood-Borne Virus (BBV) testing policy in prisons’ was held on Thursday 21 May 2015 in Birmingham. This event followed on from one held in 2014 to launch the opt-out BBV testing policy which was originally agreed by PHE, National Offender Management Service (NOMS) and NHS England in their first National Partnership Agreement, which was published in 2013 and which committed to providing BBV testing (HIV, hepatitis B and hepatitis C) for all prisoners in England.

    England Aug 2015 Reports & Research, Strategy & Planning PDF
  • Hepatitis C in the UK: 2015 report
    This annual report, from Public Health England, provides an overview of the current hepatitis C landscape across the UK. Its key findings include:

    - An estimated 214,000 people have chronic hepatitis C in the UK.

    - Deaths from hepatitis C-related end stage liver disease and liver cancer have doubled in the last decade.

    - The numbers of tests carried out in primary care is increasing, suggesting that awareness of hepatitis C may be increasing in this setting.

    UK Jul 2015 Other, Reports & Research, Strategy & Planning PDF
  • HCV Action & PHE hepatitis C roadshow in London: Presentations
    On 26th June 2015, HCV Action and Public Health England (PHE) staged a hepatitis C good practice roadshow in London. The event was designed to showcase and share best practice in the prevention, diagnosis, testing and treatment of hepatitis C, and identify specific issues and potential solutions for tackling hepatitis C in the capital.
    UK, Greater London Jul 2015 Case study, Other, Reports & Research, Tools & Templates, Strategy & Planning PDF
  • Turning Evidence into Practice: Improving access to, and completion of, hepatitis C treatment
    This briefing, produced by Public Health England, has practical advice for commissioners and services on improving access to, and completion of, hepatitis C treatment. It provides an overview of the key local issues that local providers and commissioners of drug and hepatitis C treatment should consider when commissioning and delivering services, and contains a series of prompts and examples of good practice.
    UK, England Jul 2015 Case study, Tools & Templates, Strategy & Planning PDF
  • Hepatitis C Virus Infection and Alcohol: Challenges and Opportunities
    This report, prepared by Professor David Goldberg and supported by Bristol Myers-Squibb, looks at the linkages between excessive alcohol consumption and hepatitis C, and explores how excessive alcohol consumption can act as a barrier to people with hepatitis C being considered for, receiving and the benefit of treatment for hepatitis C.

    The report contains a number of recommendations, including that for hepatitis C-infected people whose consumption of alcohol exceeds mild levels, the management of such consumption should be taken as seriously as the management of their hepatitis C.
    UK Jun 2015 Other, Reports & Research, Strategy & Planning PDF
  • Hepatitis C in the North West - PHE 2014 report
    The Public Health England North West annual hepatitis C report (published 22 June 2015) reveals that in 2014 at least 40,000 adults in the region are estimated to be infected with hepatitis C, with the highest burden of disease in Greater Manchester. Estimates indicate that the greatest numbers of people in the North West living with hepatitis C live within Lancashire, Manchester and Liverpool.
    North West Reports & Research, Strategy & Planning PDF

Pages